RxDoctor Payments DataLook up a doctor →

Daniel Kline, MD

Physical Medicine & Rehabilitation · Branford, CTNPI 1780847145

Payments from drug & device makers

$9,549in general payments, 2019–2025

Across 429 payments — averaging $22.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Lilly USA, LLC$1K
  • Medtronic$934
  • Amgen$556
  • Sunovion Pharmaceuticals Inc.$458
  • Novartis$445
  • plus $5K from 52 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)66$1,257
Lilly USA, LLC51$1,047
Medtronic8$934
Amgen23$556
Sunovion Pharmaceuticals Inc.21$458
Novartis27$445
Lundbeck LLC22$389
Teva Pharmaceuticals USA, Inc.15$374
Upsher-smith Laboratories LLC16$319
Biohaven Pharmaceuticals, Inc.14$254
SPR Therapeutics, Inc2$227
UCB, Inc.10$226
Boston Scientific5$214
Biogen16$213
Harmony Biosciences LLC7$185
Arbor Pharmaceuticals, Inc.9$182
E.r. Squibb & Sons, L.L.C.9$161
Avanir Pharmaceuticals, Inc.10$146
Biohaven Pharmaceutical Holding Company Ltd.7$144
EMD Serono, Inc.5$132
Neurocrine Biosciences, Inc.5$121
Jazz Pharmaceuticals Inc.7$120
Amneal Pharmaceuticals LLC6$119
Bristol Myers Squibb6$101
Pfizer4$86
Assertio Therapeutics, Inc.4$76
Acorda Therapeutics, Inc4$72
Kyowa Kirin, Inc.3$59
Adamas Pharmaceuticals, Inc.3$59
Livanova USA, Inc.3$54
Merz North America, Inc.1$53
Vertex2$48
Neurelis, Inc.3$46
Supernus Pharmaceuticals, Inc.2$46
Xeris Pharmaceuticals, Inc.2$45
Impel Pharmaceuticals Inc.2$44
Merz Pharmaceuticals, LLC1$43
Eisai Inc.2$37
Otsuka America Pharmaceutical, Inc.2$33
Currax Pharmaceuticals LLC2$31
Argenx US, Inc.2$31
Avion Pharmaceuticals2$31
Idorsia Pharmaceuticals US Inc2$30
Azurity Pharmaceuticals, Inc.1$30
Axsome Therapeutics, Inc.1$27
AstraZeneca1$27
Flowonix Medical Incorporated2$26
Grifols USA, LLC1$22
Scilex Pharmaceuticals Inc.1$22
Piramal Critical Care1$21
Octapharma USA, Inc.1$19
Si-bone, Inc.1$19
Vertical Pharmaceuticals, LLC1$17
Promius Pharma LLC1$17
Johnson & Johnson1$17
Abbott1$13
Collegium Pharmaceutical, Inc.1$13
Zyla Life Sciences, Inc.1$11

How this compares

$9,549 in reported general payments places this provider in the 95th percentile of 107 physical medicine & rehabilitation providers in Connecticut.

See all physical medicine & rehabilitation providers in Connecticut

Medicare billing

Part B allowed, 2024
$149,676
Medicare patients
298
Services billed
2,743

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other physical medicine & rehabilitation in Branford

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →